Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.
- NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_assertion description "[Erythropoietin (EPO) is of great interest as a therapy for many of the central nervous system (CNS) diseases and its administration is protective in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.
- NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_assertion evidence source_evidence_literature NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.
- NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_assertion SIO_000772 18670620 NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.
- NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_assertion wasDerivedFrom befree-20140225 NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.
- NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_assertion wasGeneratedBy ECO_0000203 NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.